The Use of Cannabis as a Treatment for Epilepsy in Adult Patients: Are Side Effects a Limitation of Use?

被引:2
作者
Tellez-Zenteno, Jose F. [1 ]
Ladino, Lady D. [2 ]
Hernandez-Ronquillo, Lizbeth [1 ]
机构
[1] Univ Saskatchewan, Div Neurol, Dept Med, Saskatoon, SK, Canada
[2] Hosp Pablo Tobon Uribe, Dept Neurol, Programa Epilepsia, Medellin, Colombia
关键词
Cannabis; CBD; Epilepsy; Treatment; Adults; ANTICONVULSANT ACTIVITY; RESISTANT EPILEPSY; MARIJUANA USE; DOUBLE-BLIND; PHASE-III; SEIZURES; COMORBIDITY; POPULATION; PSYCHOSIS; SCHIZOPHRENIA;
D O I
10.1097/WNP.0000000000000637
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Marijuana is the dried leaves, stems, and flowers of a 1- to 5-m weed originating from Central Asia. The most common varieties are Cannabis sativa and Cannabis indica. It is usually inhaled as smoke but can also be used as a vapor, taken by mouth as a spray, ingested in tea or as butter in baked goods, or in capsule form and used as an oil. Cannabis has been widely used to treat many medical conditions such as multiple sclerosis symptoms, mood disorders, pain, sleep disorders, and seizures among others. Preclinical and clinical studies have been done over the past decade, among them there are few randomized placebo-controlled trials. In the last few years, Cannabis has been proposed as a potential therapy for patients with drug-resistant epilepsy. This review analyzes the best information about the use of cannabis in adult patients, reviewing aspects of efficacy and safety.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 52 条
[1]   CANNABIS AND SCHIZOPHRENIA - A LONGITUDINAL-STUDY OF SWEDISH CONSCRIPTS [J].
ANDREASSON, S ;
ENGSTROM, A ;
ALLEBECK, P ;
RYDBERG, U .
LANCET, 1987, 2 (8574) :1483-1486
[2]   SCHIZOPHRENIA IN USERS AND NONUSERS OF CANNABIS - A LONGITUDINAL-STUDY IN STOCKHOLM COUNTY [J].
ANDREASSON, S ;
ALLEBECK, P ;
RYDBERG, U .
ACTA PSYCHIATRICA SCANDINAVICA, 1989, 79 (05) :505-510
[3]   Comparative Epidemiology of Dependence on Tobacco, Alcohol, Controlled Substances, and Inhalants: Basic Findings From the National Comorbidity Survey [J].
Anthony, James C. ;
Warner, Lynn A. ;
Kessler, Ronald C. .
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 1994, 2 (03) :244-268
[4]   Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study [J].
Arseneault, L ;
Cannon, M ;
Poulton, R ;
Murray, R ;
Caspi, A ;
Moffitt, TE .
BRITISH MEDICAL JOURNAL, 2002, 325 (7374) :1212-1213
[5]   The epidemiology of epilepsy: the size of the problem [J].
Bell, GS ;
Sander, JW .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2001, 10 (04) :306-316
[6]  
Berkovic Samuel F, 2005, Aust Fam Physician, V34, P1017
[7]   Vagus nerve stimulation for epilepsy: a review [J].
Binnie, CD .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2000, 9 (03) :161-169
[8]  
Brust J C, 1992, Trans Am Clin Climatol Assoc, V103, P176
[9]   The Psychosis-like Effects of Δ9-Tetrahydrocannabinol Are Associated With Increased Cortical Noise in Healthy Humans [J].
Cortes-Briones, Jose A. ;
Cahill, John D. ;
Skosnik, Patrick D. ;
Mathalon, Daniel H. ;
Williams, Ashley ;
Sewell, R. Andrew ;
Roach, Brian J. ;
Ford, Judith M. ;
Ranganathan, Mohini ;
D'Souza, Deepak Cyril .
BIOLOGICAL PSYCHIATRY, 2015, 78 (11) :805-813
[10]   CHRONIC ADMINISTRATION OF CANNABIDIOL TO HEALTHY-VOLUNTEERS AND EPILEPTIC PATIENTS [J].
CUNHA, JM ;
CARLINI, EA ;
PEREIRA, AE ;
RAMOS, OL ;
PIMENTEL, C ;
GAGLIARDI, R ;
SANVITO, WL ;
LANDER, N ;
MECHOULAM, R .
PHARMACOLOGY, 1980, 21 (03) :175-185